NCT06787014View on ClinicalTrials.gov

Resection of the Primary Tumor vs. Systemic Treatment Alone for Patients With Small Intestinal Neuroendocrine Tumors and Unresectable Metastases: a Europe-wide Study

Not yet recruitingOBSERVATIONAL

Enrollment

3,200

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

July 1, 2025

Study Completion Date

December 31, 2027

Conditions

Neuroendocrine (NE) TumorsMetastasisBowel Obstruction

Interventions

OTHER

Histopathological review

Trial Locations (1)

3010

UHI Berne, Bern

All Listed Sponsors

lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT06787014 - Resection of the Primary Tumor vs. Systemic Treatment Alone for Patients With Small Intestinal Neuroendocrine Tumors and Unresectable Metastases: a Europe-wide Study | Biotech Hunter | Biotech Hunter